Related Experiment Video
Updated: Aug 16, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Chemotherapeutic approaches to soft tissue sarcomas
1Department of Oncology, Mayo Medical School, Mayo Clinic, Rochester, Minnesota 55905.
Abstract:
Conventional chemotherapy for adult type soft tissue sarcomas is not very effective. Rarely are patients with advanced soft tissue sarcomas curable by systemic chemotherapy. Thus, the benefits from chemotherapy have been equivocal even when treatment is given postoperatively to patients whose primary sarcomas have been excised. Current research is directed toward the achievement of a high percentage of complete tumor regressions in patients with advanced metastatic disease in hope that this can be translated into truly effective adjuvant therapy. Several recent new approaches to systemic treatment for soft tissue sarcomas are assessed including prospects for possible enhancement of chemotherapy by agents which stimulate cellular immunity. Some unexpectedly favorable responses to chemotherapy+granulocyte-macrophage colony-stimulating factor (GM-CSF) in an ongoing study are discussed.
Insights
Chemotherapy for soft tissue sarcomas shows limited success. Combining chemotherapy with granulocyte-macrophage colony-stimulating factor (GM-CSF) demonstrates promising results in early studies for advanced sarcomas.
Area of Science:
- Medical Oncology
- Immunology
Background:
- Conventional chemotherapy offers limited efficacy for adult soft tissue sarcomas, with rare cures in advanced cases.
- Postoperative chemotherapy benefits remain equivocal, even after primary tumor excision.
Observation:
- Research focuses on achieving complete tumor regressions in metastatic disease for effective adjuvant therapy.
- New systemic treatment approaches are being evaluated, including immune-stimulating agents.
Findings:
- Unexpectedly favorable responses observed with chemotherapy combined with granulocyte-macrophage colony-stimulating factor (GM-CSF).
- Ongoing study results suggest potential enhancement of chemotherapy efficacy.
Implications:
- GM-CSF combination therapy may offer a more effective treatment strategy for advanced soft tissue sarcomas.
- Further research could translate these findings into improved adjuvant therapies for sarcoma patients.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy

